Research > ETFs > ETF / ETP Commentary > 

This Emerging Markets ETF’s Exclusionary Tactics Are Working

The elephant in the emerging markets (EM) room is China, and not just because it’s the world’s second-largest economy behind only the U.S. By virtue of that heft, China is also, typically, the biggest geographic exposure in traditional diversified EM exchange traded funds.Obviously, that’s good when China stocks are performing well and not so great when those stocks are lagging, as is the case today. Hence, the elephant in the room. However, investors can mute China risk in their portfolios via ETFs such as the KraneShares MSCI Emerging Markets ex China Index ETF (KEMX C+). The fund, which recently turned five years old, follows the MSCI Emerging Markets ex China Index. As is the case with any other asset, there are potential risks and rewards with KEMX. The risk is that the ETF won’t directly participate in a China equity market rebound when that scenario materializes. The reward is that when Chinese stocks lag, KEMX won’t feel severe punishment. In fact, the KraneShares fund is higher by 12.72% over the past year — a period in which the MSCI Emerging Markets Index gained just 6.23%.What Makes KEMX ClickA standard recipe employed by ex-China ETFs is to increase weights to India, South Korea, and Taiwan. KEMX follows suit, as those three countries combine for nearly two-thirds of the ETF’s geographic exposure compared to about 43% for the category average. KEMX’s large weight to India has benefited investors, because while China stocks have struggled over the past several years, India equities have been among the best performers in the world — a trend that’s continuing this year. Likewise, KEMX’s elevated exposure to Taiwan tethers investors to a high-quality, tech-rich economy. “Emerging-markets ex China funds tend to have more exposure to Brazil and Mexico, which have their own economic, social, and political downsides. Both countries have been accused of having corrupt governments, which have led to political uprisings,” noted Morningstar’s David Carey. In terms of other developing markets, Brazil and Mexico are Latin America’s two largest economies. Carey’s assertion that both have had bouts with corruption and political volatility is accurate. KEMX’s allocations to those countries is above what’s found in a standard emerging markets fund. But the ETF devotes less than 13% of its total weight to stocks from that pair of nations. Bottom line: KEMX and its peers aren’t perfect, but these products are worthy of consideration by tactical investors at a time when Chinese stocks are lagging. “Emerging-markets ex China funds help solve some problems but create others. On one hand, they allow investors to minimize or eliminate China exposure, but they increase helpings in other developing markets with their own issues,” concluded Carey.For more news, information, and analysis, visit the China Insights Channel.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.